Treatment of depression: are we finally on the right track?

References

• Cuijpers P, Van Straten A, Van Oppen P, et al. Are psychological and pharmacologic interventions equally effective in the treatment of adult depressive disorders? A meta-analysis of comparative studies. J Clin Psychiatry 2008;69:1675-85
   PubMed Web of Science ®Google Scholar
• Nelson J, Qianiy Z, Kelin K, et al. Baseline characteristics associated with placebo remission and their impact on remission with duloxetine and selected SSRI antidepressants. Curr Med Res Opin in press
   Google Scholar
• Brnabic A, Lin C, Monkul ES, et al. Major depressive disorder severity and the frequency of painful physical symptoms: a pooled analysis of observational studies. Curr Med Res Opin 2012;28:1891-7
   PubMed Web of Science ®Google Scholar
• Roth A, Fonagy P. What works for whom? A Critical Review of Psychotherapy Research, 2nd edn. New York: Guilford Press, 2004
   Google Scholar
• Nelson JC, Zhang Q, Deberdt W, et al. Predictors of remission with placebo using an integrated study database from patients with major depressive disorder. Curr Med Res Opin 2012;28:325-34
   PubMed Web of Science ®Google Scholar
• Wang J, Liu X, Mullins CD. Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases. Curr Med Res Opin 2011;27:1303-13
   PubMed Web of Science ®Google Scholar
• Demyttenaere K, Corruble E, Hale A, et al. A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline. CNS Spectrums in press
   Google Scholar
• Luyten P, Blatt SJ. Relatedness and self-definition in Normal and Disrupted Personality Development: Retrospect and Prospect. Am Psychol 2013;68:172-83
   Google Scholar
• Way BM, Lieberman MD. Is there a genetic contribution to cultural differences? Collectivism, individualism and genetic markers of social sensitivity. Soc Cognit Affect Neurosci 2010;5:203-11
   PubMed Web of Science ®Google Scholar
• Ministerio de Salud (MINSAL) Peru. Mortalidad por Causas, Según Sexo. Chile 2000–2009 [Mortality causes and gender. Chile 2000–2009]. 2010. Available at: http://www.deis.cl/ [Last accessed April 12, 2013]
   Google Scholar
• Organization for Economic Co-Operation and Development. OECS Factbook 2013. Economic, Environmental and Social Statistics. OECD Publishing, 2013
   Google Scholar
• Im J-S, Choi SH, Hong D, et al. Proximal risk factors and suicide methods among suicide completers from national suicide mortality data 2004–2006 in Korea. Compr Psychiatry 2011;52:231-7
   PubMed Web of Science ®Google Scholar
• Kwon J-W, Chun H, Cho S-I. A closer look at the increase in suicide rates in South Korea from 1986–2005. BMC Public Health 2009;9:72
   PubMed Web of Science ®Google Scholar
• Aitchison K, Basu A, McGuffin P, Craig I. Psychiatry and the ‘new genetics': hunting for genes for behaviour and drug response. Br J Psychiatry 2005;186:91-2
   PubMed Web of Science ®Google Scholar
• Kazdin AE. Evidence-based treatment research: advances, limitations, and next steps. Am Psychol 2011;66:685-98
   PubMed Web of Science ®Google Scholar
• Blatt SJ, Zuroff DC, Hawley LL, Auerbach JS. Predictors of sustained therapeutic change. Psychother Res 2010;20:37-54
   PubMed Web of Science ®Google Scholar
• Van HL, Dekker J, Peen J, et al. Identifying patients at risk of complete nonresponse in the outpatient treatment of depression. Psychother Psychosom 2008;77:358-64
   PubMed Web of Science ®Google Scholar
• Kapur S, Phillips AG, Insel TR. Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol Psychiatry 2012;17:1174-9
   PubMed Web of Science ®Google Scholar
• Heim C, Newport DJ, Mletzko T, et al. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 2008;33:693-710
   PubMed Web of Science ®Google Scholar
• Luyten P, Fonagy P, Lemma A, et al. Depression. In: Bateman A, Fonagy P, eds. Handbook of Mentalizing in Mental Health Practice. Washington, DC: American Psychiatric Association, 2012:385-417
   Google Scholar
• Luyten P, Blatt SJ, Van Houdenhove B, Corveleyn J. Depression research and treatment: are we skating to where the puck is going to be? Clin Psychol Rev 2006;26:985-99
   PubMed Web of Science ®Google Scholar
• Cicchetti D, Rogosch FA. Equifinality and multifinality in developmental psychopathology. Dev Psychopathol 1996;8:597-600
   Web of Science ®Google Scholar
• Insel TR, Cuthbert BN. Endophenotypes: bridging genomic complexity and disorder heterogeneity. Biol Psychiatry 2009;66:988-9
   PubMed Web of Science ®Google Scholar
• Hudson JI, Mangweth B, Pope HG Jr, et al. Family study of affective spectrum disorder. Arch Gen Psychiatry 2003;60:170-7
   PubMed Web of Science ®Google Scholar
• Wessely S, White P. There is only one functional somatic syndrome. Br J Psychiatry 2004;185:95-6
   PubMed Web of Science ®Google Scholar
• Luyten P, Van Houdenhove B, Lemma A, et al. Vulnerability for functional somatic disorders: a contemporary psychodynamic approach. J Psychotherapy Integration in press
   Google Scholar
• Eisenberger NI, Lieberman MD, Williams KD. Does rejection hurt? An FMRI study of social exclusion. Science 2003;302:290-2
   PubMed Web of Science ®Google Scholar
• Häuser W, Wolfe F, Tölle T, et al. The role of antidepressants in the management of fibromyalgia syndrome. CNS Drugs 2012;26:297-307
   PubMed Web of Science ®Google Scholar
• Dinos S, Khoshaba B, Ashby D, et al. A systematic review of chronic fatigue, its syndromes and ethnicity: prevalence, severity, co-morbidity and coping. Int J Epidemiol 2009;38:1554-70
   PubMed Web of Science ®Google Scholar
• Tyrer P. From the editor's desk: the end of the psychopharmacological revolution. Br J Psychiatry 2012;201:168
   Web of Science ®Google Scholar